Evaluation of the Biograph Vision Quadra Total-Body PET Scanner for Enhanced Imaging in Adults With Lung, Head and Neck, or Prostate Cancer

What this Trial Is About

Researchers are evaluating a new total-body PET scanner called the Biograph Vision Quadra to see if it can produce better PETCT images and provide more detailed imaging information compared to standard PETCT scanners. This study focuses on adults with lung, head and neck, or prostate cancer who are undergoing routine or clinical trial PETCT scans. Participants will undergo one or two additional PETCT scans using the Biograph Vision Quadra scanner during their scheduled imaging sessions. These extra scans may include breath-hold, dynamic, or delayed image acquisitions. The study collects additional imaging data from patients already scheduled for PETCT as part of their standard care or ongoing clinical trials. During the study, participants will have standard PETCT scans along with the additional scans from the new scanner. Researchers will assess image quality over a three-year period. Participants may be asked to return for late imaging sessions several hours after the radiotracer injection. The study involves no investigational treatments, focusing on imaging data collection and quality improvement, with the total participation duration depending on scheduling and imaging needs.

A Study of a New PET Scanner in People With Cancer